He will lead the development of the company’s global biopharmaceutical CDMO platform spanning vaccines, antibody-drug ...

We are expanding into the Middle East, Southeast Asia and Africa, where high musculoskeletal disease burden, growing private ...

The industry's more rigorous players are likely to pull further ahead over the coming years, not through any single ...

Godavari Biorefineries Limited has received official approval from the Mexican Patent Office (Instituto Mexicano de la ...

We are expanding into the Middle East, Southeast Asia and Africa, where high musculoskeletal disease burden, growing private healthcare and demand for affordable quality care create strong opportuniti ...

Aurobindo Pharma Limited has successfully completed its acquisition of the Contract Research Services business of A1 Biochem ...

Multi-year investment reinforces U.S. business expansion and adds to $7 billion in U.S. pharma R&D and manufacturing ...

Ayush services economy could scale to US $216–318 billion by 2047 subject to the strengthening of infrastructure, quality ...

The transaction outlines a subscription where Zydus Lifesciences will purchase 50% of the total paid-up equity share capital ...

Zealand Pharma’s investigational obesity drug survodutide delivered sustained weight loss and improved blood sugar control in ...